EXPONENT INC

Company Overview

Exponent, Inc. is a multidisciplinary science and engineering consulting firm (ticker: EXPO) that provides project-based technical, scientific, regulatory and litigation support across end markets including consumer products (~24% of 2024 revenues), energy and utilities (~19%), transportation (~16%) and chemicals (~10%). The business is organized into two reportable segments (Engineering and Other Scientific; Environmental & Health) delivered via 16 specialized practices and supported by significant lab/testing infrastructure and internal R&D (battery modeling, fire/explosion, data science). 2024 revenues were $558.5M with 1,168 employees (917 technical staff, 874 with advanced degrees), billable hours ~1.495M and utilization of 73%; the market is fragmented, client engagements are often terminable, and demand is lumpy and litigation/regulatory driven.

Executive Compensation Practices

Compensation at Exponent is driven primarily by utilization, billable hours, billing-rate realization and segment profitability—metrics management cites as the main levers for margin improvement—so annual bonuses and short-term incentives are likely tied to utilization and revenue-before-reimbursements, with long-term pay provided via stock-based awards and deferred compensation. Reported compensation expense rose modestly in 2024 (+3.2%) but showed substantial volatility in 2025 Q2 (+22.7%) driven largely by valuation changes in the company’s large nonqualified deferred compensation plan (assets/liabilities ≈ $115M), making reported GAAP compensation and other income more volatile than underlying cash pay. The company also emphasizes selective hiring and retention of highly credentialed technical staff (declining technical FTEs are a retention risk), so you can expect retention bonuses, sign-on awards and equity grants to be used strategically alongside market-level salary increases and periodic promotions.

Insider Trading Considerations

Insiders at Exponent will commonly hold compensation tied to equity and a large nonqualified deferred compensation plan, so filings may show clustered activity around vesting dates, bonus payments, or changes in deferred-compensation valuations; given the firm’s healthy cash balance and active buybacks/dividends, insiders may also time sales in the context of repurchase programs. Because revenue and margins depend on utilization, billable hours and episodic litigation/regulatory outcomes, material nonpublic events (major case rulings, large engagements, regulatory submissions or sudden client terminations) are likely to produce informative insider trades and therefore trigger blackout windows. Traders should monitor Form 4 and 10b5‑1 plan disclosures, Section 16 filings and changes in deferred-compensation balances or lease/expense items called out by management, as these items have driven recent volatility in reported compensation and could precede meaningful stock moves.